Colfax Corporation (CFX) |
| 39.06 -1.53 (-3.77%) 04-05 00:00 |
| Open: | 40.6 |
| High: | 40.67 |
| Low: | 38.88 |
| Volume: | 2,953,345 |
| Market Cap: | 2,122(M) |
| PE Ratio: | 28.55 |
| Exchange: | New York Stock Exchange |
| Industry: | Industrial - Machinery |
| Sector: | Industrials |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 84.20 |
| Resistance 1: | 72.09 |
| Pivot price: | 65.94 |
| Support 1: | 63.57 |
| Support 2: | 58.30 |
| 52w High: | 94.02802 |
| 52w Low: | 38.88 |
Colfax Corporation operates as a global, diversified technology enterprise, structured into two primary divisions: Fabrication Technology and Medical Technology. The Fabrication Technology division specializes in the formulation, development, manufacturing, and supply of consumable products and associated equipment. These are crucial for industrial applications such as cutting, joining, automated welding, and gas flow control. Its comprehensive product portfolio includes a variety of welding consumables, like electrodes, wires, and fluxes, alongside cutting consumables such as nozzles, shields, and tips. These items are distributed through independent channels and direct sales to diverse markets, including general industry, construction, infrastructure, transportation, energy, and medical and life sciences, predominantly under the ESAB brand. Conversely, the Medical Technology division is dedicated to the development, production, and distribution of advanced medical devices. These devices are utilized by a broad spectrum of healthcare practitioners, including orthopedic specialists, surgeons, physical therapists, and athletic trainers, to manage musculoskeletal conditions caused by degenerative diseases, deformities, traumatic incidents, and sports-related injuries. Its extensive product offerings encompass rigid and soft orthopedic bracing, hot and cold therapy systems, bone growth stimulators, vascular therapy solutions, therapeutic footwear, electrical stimulators for pain management, and a full range of reconstructive joint implants for areas like the hip, knee, and shoulder. Sales for this segment, primarily under the DJO brand, occur via independent distributors (such as healthcare professionals and retail pharmacies) and direct channels. Established in 1860, Colfax Corporation is headquartered in Wilmington, Delaware.
| EPS | 1.890 |
| Book Value | 13.570 |
| PEG Ratio | 4.44 |
| Gross Profit | 7.090 |
| Profit Margin (%) | 10.34 |
| Operating Margin (%) | 31.07 |
| Return on Assets (ttm) | 7.8 |
| Return on Equity (ttm) | 15.6 |
Mon, 08 Jun 2026
Colfax Corporation (CFX) R&D/CAPEX US GAAP (year values) - Smart-Lab
Mon, 08 Jun 2026
Colfax Corporation Financial Statements (CFX) - Smart-Lab
Fri, 25 Apr 2025
CFX Stock Price, News & Analysis - Stock Titan
Tue, 22 Feb 2022
Colfax Corporation Announces Fourth Quarter and Full Year 2021 Results - Yahoo Finance
Sat, 30 Oct 2021
Starboard Value spots fresh opportunities for diversified tech company Colfax - CNBC
Mon, 07 Dec 2020
Colfax Stock Price Forecast. Should You Buy CFX? - StockInvest.us
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |